Covaxin trial in Kolkata from December 2, TMC minister Firhad Hakim may get first shot

By: |
November 30, 2020 9:42 PM

"It is a great feat that he has expressed his willingness to be a part of the prorgamme and we will be happy to enrol him. He requires to take a few screening tests, following which the next step will be decided," the official added.

According to the company, the vaccine is developed and manufactured at Bharat Biotech's BSL-3, biocontainment facility.According to the company, the vaccine is developed and manufactured at Bharat Biotech's BSL-3, biocontainment facility.

The phase III trial of Covaxin — the vaccine for COVID-19 — at the National Institute of Cholera and Enteric Disease (NICED) in Kolkata will start from Wednesday, a senior official said. State Urban Development Minister Firhad Hakim (62) is likely to be the volunteer to take the first shot of Covaxin if everything goes according to plan and he is found to be fit in the medical tests, the official of the institute said on Monday.

“The phase III trials of Covaxin will be starting on December 2. We have requested some of the applicants, including Hakim, to appear for the trials on that day. They will be administered the vaccine only after they test fit for the trials. They cannot have any comorbidities. Following satisfactory results, the shots will be administered to them,” the official said. Hakim, also the chief of the Kolkata Municipal Corporation, had earlier expressed wish to be a volunteer for the trials.

“It is a great feat that he has expressed his willingness to be a part of the prorgamme and we will be happy to enrol him. He requires to take a few screening tests, following which the next step will be decided,” the official added.

Asked whether the senior Trinamool Congress leader will be getting the vaccine or the placebo, he said that since the phase III trial of Covaxin is a double-blinded placebo-controlled study, neither the volunteer nor the investigator will be able to know who is receiving what. Half of the volunteers will be receiving the first-candidate vaccines, indigenously developed by Hyderabad-based Bharat Biotech and the ICMR, while the rest will be given placebos, he said. Another shot will be administered to each of the volunteers after four weeks of the first one. At least 1,000 volunteers will be administered the Covaxin in the phase III trials in Kolkata.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Coronavirus Live Updates: 30,773 new Covid-19 cases recorded, 13.7% less than Saturday
2WHO Experts’ Group to take a call on EUL for Covaxin on October 6
3Centre keen to provide efficient, inclusive healthcare services to people of Jammu and Kashmir: Union Health Minister Mansukh Mandaviya